It’s a Girl! And Three Small-Cap Breakouts

My wife had our second child, a gorgeous little girl, a few weeks ago.

“Big things come in small packages,” they say.

And I’m amazed at the unbelievable potential that humans have, starting as just “little” babies.

I’m going to let you in on a secret…

The potential that “little” stocks hold is almost as powerful.

And they’re responsible for the market’s biggest gains.

That’s right.

Of the 10 biggest stock winners on US exchanges in 2020, none of them are large-cap stocks.

In fact, all of this year’s top 10 stocks traded for less than $10 at the start of the year.

But unlike the attention that cute babies like my daughter get…

Small stocks get hardly any love from mainstream financial media.

Which is why you’ve probably never heard of the tiny biotech firm Novavax Inc. (NVAX).

(Well, unless you watched my chart video in July.)

nvax

The stock’s up more than 3,100% this year. And 2020’s top performer traded for less than $2 on Jan. 1.

Vaxart Inc. (VXRT), the second-best performing stock in 2020, has quietly gained 2,100%.

It was a $0.12 stock at the start of the year.

And Bitcoin miner Bit Digital Inc. (BTBT) is up 1,800%.

These surging shares closed at $0.33 when the stock went public in March.

The well-known big tech firms Apple, Microsoft and Facebook, by comparison, are only up by a fraction of those heady gains.

(And these big ol’ stocks would have cost you a whole lot more to get into.)

Best of all, there are thousands of tiny companies ready to explode even as I write.

So as an early “2021 present” to you…

I’m going to reveal three of my favorite breakout small-cap stocks under $10 right now.

Small-Cap Pick #1: The Case for the Space Race

Man, I love Orbcomm Inc. (ORBC).

I mean, who doesn’t love space?

This small satellite tech company is a big player in the 5G game.

And a flood of money is flowing into the stock as 2020 comes to a close…

orbc chart

The stock has more than tripled off its March low.

(In fact, I highlighted this surging “space race” stock back in July — beforethe stock popped 80%.)

However, as you can see above…

Shares finally broke through pesky resistance at $4.50 last month on the company’s strong Q3 earnings report.

My first price target on the stock is $7.50. (That’s the $3 range from March low at $1.50 added to the $4.50 breakout point)

Even better, on 5G’s strong rollout worldwide…

I think there’s enough momentum to send the stock back to its 2017 high at $12.

That move would almost double your money.

Small-Cap Picks #2 & #3: It’s Time to Bet Big on Biotech

COVID-19 has wrecked the year for many people.

But there is one great thing to come out of this awful pandemic…

Rapid biotechnology innovation to kill this bug.

And just like the space race of the 20th century led to big tech breakthroughs for the world…

The race to kill COVID will spawn a host of new vaccines and treatments for a wide range of diseases.

As a result, stocks of biotech firms will soar higher over the next decade.

And the smallest biotech stocks are going to see the biggest pops.

Cancer-fighting firms ImmunoGen Inc. (IMGN) and BioCryst Pharmaceuticals Inc. (BCRX) are two such names.

ImmunoGen focuses on highly-targeted antibody drug therapies to kill cancer.

And investors are piling into this tiny stock headfirst right now…

IMGN chart

For much of the year, shares have traded in a range between $6.50 and $2.50 at the low in March.

But the stock broke out to the upside this week as the first COVID vaccines rolled out.

On IMGN’s breakout, I expect shares to hit $10.50.

That’s an upside of more than 40% from the stock’s close on Tuesday.

The last small-cap on my list, BioCryst Pharmaceuticals, has been fighting already COVID with powerful antiviral drugs.

But it also has a number of cancer and rare disease drugs in late-stage clinical trials.

That’s why the stock is popping as big money moves into the biotech space.

bcrx chart

Through 2020, shares have carved out a range between $5.50 and $1.50.

And like ImmunoGen, BioCryst shares have broken out as COVID vaccines got the green light.

The breakout here targets $9.50 — which is just below the stock’s 2019 high.

But if the stock can blast through last year’s top… the next stop is $15.

That’s an upside of more than 80% from the stock’s current level.

And anyone of these three breakout stocks could be at the top of 2021’s stock winners list.

Bottom line: If you want slow, safe, methodical gains… Stick with the brand-name large-cap stocks. But if you’re looking for life-changing profits, stock up on small-cap stocks and watch ’em grow up.

On the hunt,

Jonathan Rodriguez

Jonathan Rodriguez

You May Also Be Interested In:

Markets in Pause Mode; World Awaits OPEC; Dems Look to Sign a $900 bil Deal – Feast of the 7 Fishes No. 2

It’s Thursday… markets around the world are mixed, US futures are mixed, The Brits are celebrating over the administration and distribution of the vaccine, The Rockefeller Christmas tree was lit, news that Nancy and Chucky (Pelosi and Schumer) are now ready to accept a $900 billion stimulus plan and OPEC+ should be making some kind of decision on what’s next for oil production? Will they continue to keep the current cuts in place or not? Let’s start there…

Jonathan Rodriguez